33635380|t|Latent trait modeling of tau neuropathology in progressive supranuclear palsy.
33635380|a|Progressive supranuclear palsy (PSP) is the second most common neurodegenerative Parkinsonian disorder after Parkinson's disease, and is characterized as a primary tauopathy. Leveraging the considerable clinical and neuropathologic heterogeneity associated with PSP, we measured tau neuropathology as quantitative traits to perform a genome-wide association study (GWAS) within PSP to identify genes and biological pathways that underlie the PSP disease process. In 882 PSP cases, semi-quantitative scores for phosphorylated tau-immunoreactive coiled bodies (CBs), neurofibrillary tangles (NFTs), tufted astrocytes (TAs), and tau threads were documented from 18 brain regions, and converted to latent trait (LT) variables using the R ltm package. LT analysis utilizes a multivariate regression model that links categorical responses to unobserved covariates allowing for a reduction of dimensionality, generating a single, continuous variable to account for the multiple lesions and brain regions assessed. We first tested for association with PSP LTs and the top PSP GWAS susceptibility loci. Significant SNP/LT associations were identified at rs242557 (MAPT H1c sub-haplotype) with hindbrain CBs and rs1768208 (MOBP) with forebrain tau threads. Digital microscopy was employed to quantify phosphorylated tau burden in midbrain tectum and red nucleus in 795 PSP cases and tau burdens were used as quantitative phenotypes in GWAS. Top associations were identified at rs1768208 with midbrain tectum and red nucleus tau burden. Additionally, we performed a PSP LT GWAS on an initial cohort, a follow-up SNP panel (37 SNPs, P < 10-5) in an extended cohort, and a combined analysis. Top SNP/LT associations were identified at SNPs in or near SPTBN5/EHD4, SEC13/ATP2B2, EPHB1/PPP2R3A, TBC1D8, IFNGR1/OLIG3, ST6GAL1, HK1, CALB1, and SGCZ. Finally, testing for SNP/transcript associations using whole transcriptome and whole genome data identified significant expression quantitative trait loci at rs3088159/SPTBN5/EHD4 and rs154239/GHRL. Modeling tau neuropathology heterogeneity using LTs as quantitative phenotypes in a GWAS may provide substantial insight into biological pathways involved in PSP by affecting regional tau burden.
33635380	25	43	tau neuropathology	Disease	MESH:C536599
33635380	47	77	progressive supranuclear palsy	Disease	MESH:D013494
33635380	79	109	Progressive supranuclear palsy	Disease	MESH:D013494
33635380	111	114	PSP	Disease	MESH:D013494
33635380	160	181	Parkinsonian disorder	Disease	MESH:D010300
33635380	188	207	Parkinson's disease	Disease	MESH:D010300
33635380	235	252	primary tauopathy	Disease	MESH:D024801
33635380	341	344	PSP	Disease	MESH:D013494
33635380	358	376	tau neuropathology	Disease	MESH:C536599
33635380	457	460	PSP	Disease	MESH:D013494
33635380	521	524	PSP	Disease	MESH:D013494
33635380	549	552	PSP	Disease	MESH:D013494
33635380	604	607	tau	Gene	4137
33635380	705	708	tau	Gene	4137
33635380	1123	1126	PSP	Disease	MESH:D013494
33635380	1143	1146	PSP	Disease	MESH:D013494
33635380	1224	1232	rs242557	SNP	tmVar:rs242557;VariantGroup:0;CorrespondingGene:4137;RS#:242557;CorrespondingSpecies:9606
33635380	1234	1238	MAPT	Gene	4137
33635380	1281	1290	rs1768208	SNP	tmVar:rs1768208;VariantGroup:2;CorrespondingGene:4336;RS#:1768208;CorrespondingSpecies:9606
33635380	1292	1296	MOBP	Gene	4336
33635380	1313	1316	tau	Gene	4137
33635380	1385	1388	tau	Gene	4137
33635380	1438	1441	PSP	Disease	MESH:D013494
33635380	1452	1455	tau	Gene	4137
33635380	1546	1555	rs1768208	SNP	tmVar:rs1768208;VariantGroup:2;CorrespondingGene:4336;RS#:1768208;CorrespondingSpecies:9606
33635380	1593	1596	tau	Gene	4137
33635380	1634	1637	PSP	Disease	MESH:D013494
33635380	1817	1823	SPTBN5	Gene	51332
33635380	1824	1828	EHD4	Gene	30844
33635380	1830	1835	SEC13	Gene	6396
33635380	1836	1842	ATP2B2	Gene	491
33635380	1844	1849	EPHB1	Gene	2047
33635380	1850	1857	PPP2R3A	Gene	5523
33635380	1859	1865	TBC1D8	Gene	11138
33635380	1867	1873	IFNGR1	Gene	3459
33635380	1874	1879	OLIG3	Gene	167826
33635380	1881	1888	ST6GAL1	Gene	6480
33635380	1890	1893	HK1	Gene	3098
33635380	1895	1900	CALB1	Gene	793
33635380	1906	1910	SGCZ	Gene	137868
33635380	2070	2079	rs3088159	SNP	tmVar:rs3088159;VariantGroup:1;CorrespondingGene:105370792;RS#:3088159;CorrespondingSpecies:9606
33635380	2080	2086	SPTBN5	Gene	51332
33635380	2087	2091	EHD4	Gene	30844
33635380	2096	2104	rs154239	SNP	tmVar:rs154239;VariantGroup:3;CorrespondingGene:6396;RS#:154239;CorrespondingSpecies:9606
33635380	2105	2109	GHRL	Gene	51738
33635380	2120	2138	tau neuropathology	Disease	MESH:C536599
33635380	2269	2272	PSP	Disease	MESH:D013494
33635380	2295	2298	tau	Gene	4137
33635380	Association	MESH:D013494	RS#:1768208;CorrespondingGene:4336
33635380	Association	MESH:D013494	491
33635380	Association	MESH:D013494	4336
33635380	Association	MESH:D013494	11138
33635380	Association	MESH:D013494	6480
33635380	Association	MESH:D013494	3098
33635380	Association	MESH:D013494	793
33635380	Association	MESH:D013494	6396
33635380	Association	MESH:D013494	3459
33635380	Association	MESH:D013494	RS#:242557;CorrespondingGene:4137
33635380	Association	MESH:D013494	137868
33635380	Association	MESH:D013494	30844
33635380	Association	MESH:D013494	167826
33635380	Association	MESH:D013494	51738
33635380	Association	MESH:D013494	RS#:154239;CorrespondingGene:6396
33635380	Association	MESH:D013494	4137
33635380	Association	MESH:D013494	RS#:3088159;CorrespondingGene:105370792
33635380	Association	MESH:D013494	51332
33635380	Association	MESH:D013494	5523
33635380	Association	MESH:D013494	2047
33635380	Association	MESH:D013494	4336
33635380	Association	MESH:D013494	4137
33635380	Association	MESH:D013494	6396
33635380	Association	MESH:D013494	105370792

